Tab 2 Research Priorities and Opportunities: Based on the priority areas enumerated above or based on any other emerging technologies, provide specific examples of innovative research opportunities, needs, and gaps to improve the Agency???s regulatory science capabilities, especially in areas that complement or enhance FDA???s existing resources.